New Born Screening

New Born Screening

Newborn Screening or Neonatal Screening is a preventive pediatric screening service performed to diagnose congenital or inborn errors of metabolism in order to identify patients and administrate treatment starting from the first weeks of life to reverse the prognosis. Early diagnosis and treatment correlates with significant reduction in mortality and associated disabilities for those affected.

Labsystems Diagnostics is the first company in the world to introduce fluorometric microplate based assay for phenylalanine for diagnosing phenylketonuria (PKU) in newborns and is the only company in the world to have an assay for the diagnosis of neonatal toxoplasmosis.

The company develops, manufactures and markets high quality enzyme immunoassays, molecular assays and Point of Care tests. Labsystems has the complete solution to newborn screening.

Next Page

Powerful yet simple

Built for all levels of expertise, whether you need simple product or complex ones, we are always willing to go the extra mile to see our clients smile.


Taking our clients to the next level is a big part of our plan going forward, watching our working relations grow, while you see your business grow.

Fit for any purpose

We create custom solutions for all our clients needs, just look at the vast amount of focus areas we cover.  

Support & Service

Our experienced support and service teams pride themselves on quick response times. Whatever your level of expertise, we’re here to help you with any questions you might have.